Identification of Crucial Amino Acid Residues for Antimicrobial Activity of Angiogenin 4 and Its Modulation of Gut Microbiota in Mice.

angiogenin 4 antimicrobial peptide microbiology microbiome ribonuclease

Journal

Frontiers in microbiology
ISSN: 1664-302X
Titre abrégé: Front Microbiol
Pays: Switzerland
ID NLM: 101548977

Informations de publication

Date de publication:
2022
Historique:
received: 21 03 2022
accepted: 09 05 2022
entrez: 23 6 2022
pubmed: 24 6 2022
medline: 24 6 2022
Statut: epublish

Résumé

Angiogenin 4 bearing ribonuclease activity is an endogenous antimicrobial protein expressed in small and large intestine. However, the crucial amino acid residues responsible for the antibacterial activity of Ang4 and its impact on gut microbiota remain unknown. Here, we report the contribution of critical amino acid residues in the functional regions of Ang4 to its activity against

Identifiants

pubmed: 35733962
doi: 10.3389/fmicb.2022.900948
pmc: PMC9207454
doi:

Types de publication

Journal Article

Langues

eng

Pagination

900948

Informations de copyright

Copyright © 2022 Sultana, Suzuki, Yamasaki, Kubota, Takahashi, Abo and Kawashima.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Biochemistry. 1989 Sep 5;28(18):7401-8
pubmed: 2479414
Biochem J. 2013 Nov 15;456(1):99-108
pubmed: 23962023
BMC Evol Biol. 2010 Oct 15;10:310
pubmed: 20950426
Front Endocrinol (Lausanne). 2020 Jan 31;11:25
pubmed: 32082260
Immunity. 2015 Jan 20;42(1):28-39
pubmed: 25607457
Bioessays. 2000 Jun;22(6):532-44
pubmed: 10842307
FEMS Microbiol Rev. 2016 Jan;40(1):133-59
pubmed: 25862689
PLoS One. 2012;7(9):e42248
pubmed: 22970115
Trends Microbiol. 2000 Sep;8(9):402-10
pubmed: 10989307
J Med Chem. 2011 Jul 28;54(14):5237-44
pubmed: 21696142
J Biol Chem. 2006 Sep 1;281(35):25622-34
pubmed: 16803891
FEBS J. 2013 Jan;280(1):302-18
pubmed: 23170778
Nat Immunol. 2003 Mar;4(3):269-73
pubmed: 12548285
Biochemistry. 2007 Mar 6;46(9):2431-43
pubmed: 17279775
Annu Rev Biomed Eng. 2021 Jul 13;23:339-357
pubmed: 33852346
Int J Syst Evol Microbiol. 2009 Jul;59(Pt 7):1805-12
pubmed: 19542111
FEBS Lett. 2015 Dec 21;589(24 Pt B):3915-20
pubmed: 26555191
Exp Biol Med (Maywood). 2005 Mar;230(3):155-70
pubmed: 15734719
Front Med Technol. 2020 Dec 11;2:610997
pubmed: 35047892
Diagn Microbiol Infect Dis. 2013 Apr;75(4):417-22
pubmed: 23514757
J Thromb Haemost. 2006 Sep;4(9):1864-74
pubmed: 16961595
Proc Natl Acad Sci U S A. 1987 Dec;84(24):8783-7
pubmed: 3122207
J Mater Chem B. 2021 Nov 10;9(43):9041-9054
pubmed: 34664611
J Biomol NMR. 2005 Feb;31(2):175-6
pubmed: 15772759
Anim Nutr. 2020 Dec;6(4):389-396
pubmed: 33364454
Gene. 2007 Dec 30;406(1-2):8-12
pubmed: 17616268
Biochem J. 2009 Jul 15;421(3):425-34
pubmed: 19450231
Biochim Biophys Acta. 2006 Sep;1758(9):1436-49
pubmed: 16678118
Front Cell Infect Microbiol. 2021 Nov 22;11:757718
pubmed: 34881193
Front Cell Dev Biol. 2019 Dec 10;7:291
pubmed: 31921835
Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2222-6
pubmed: 2006161
Nat Commun. 2020 Aug 4;11(1):3888
pubmed: 32753666
Biochemistry. 1985 Sep 24;24(20):5480-6
pubmed: 4074709
J Biol Chem. 2007 Feb 16;282(7):4626-4633
pubmed: 17150966
FEBS J. 2010 Apr;277(7):1713-25
pubmed: 20180804
Acta Biochim Biophys Sin (Shanghai). 2016 May;48(5):399-410
pubmed: 26705141
Pharmaceuticals (Basel). 2021 Aug 24;14(9):
pubmed: 34577539
Front Immunol. 2020 Jun 09;11:906
pubmed: 32582143
Antimicrob Agents Chemother. 1991 Jul;35(7):1309-14
pubmed: 1656859
Mol Divers. 2006 Nov;10(4):585-97
pubmed: 16969722
Nat Biotechnol. 2006 Dec;24(12):1551-7
pubmed: 17160061
Trends Immunol. 2014 Sep;35(9):443-50
pubmed: 25113635
Int J Syst Evol Microbiol. 2004 Sep;54(Pt 5):1469-1476
pubmed: 15388697
PLoS One. 2013 Dec 17;8(12):e84553
pubmed: 24358364
Genomics. 2005 Feb;85(2):208-20
pubmed: 15676279

Auteurs

Mst Farzana Sultana (MF)

Laboratory of Microbiology and Immunology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan.
Department of Pharmacy, Jashore University of Science and Technology, Jashore, Bangladesh.

Maki Suzuki (M)

Laboratory of Microbiology and Immunology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan.

Fumiya Yamasaki (F)

Laboratory of Microbiology and Immunology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan.

Wataru Kubota (W)

Laboratory of Microbiology and Immunology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan.

Kohta Takahashi (K)

Laboratory of Microbiology and Immunology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan.

Hirohito Abo (H)

Laboratory of Microbiology and Immunology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan.

Hiroto Kawashima (H)

Laboratory of Microbiology and Immunology, Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan.

Classifications MeSH